(2R,5S)-N-[(2S)-3-(cyclohexen-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-2-[(4-methoxyphenyl)methyl]-5-[(2-morpholin-4-ylacetyl)amino]-5-(oxetan-3-yl)-4-oxopentanamide;(2R)-N-[(2S,5R)-5-(cyclopenten-1-ylmethyl)-1-(4-methoxyphenyl)-6-[(2R)-2-methyloxiran-2-yl]-3,6-dioxohexan-2-yl]-2-(3-morpholin-4-yl-2-oxopropyl)pent-4-ynamide;(2R)-N-[(2S,5R)-5-(cyclopenten-1-ylmethyl)-1-(2-methoxy-4-pyridinyl)-6-[(2R)-2-methyloxiran-2-yl]-3,6-dioxohexan-2-yl]-2-methyl-5-morpholin-4-yl-4-oxopentanamide;(2R)-N-[(2S,5R)-5-(cyclopenten-1-ylmethyl)-1-(6-methoxy-3-pyridinyl)-6-[(2R)-2-methyloxiran-2-yl]-3,6-dioxohexan-2-yl]-2-methyl-5-morpholin-4-yl-4-oxopentanamide;(2R)-N-[(2S,5R)-5-(cyclopenten-1-ylmethyl)-6-[(2R)-2-methyloxiran-2-yl]-1-(1-methyl-2-oxo-4-pyridinyl)-3,6-dioxohexan-2-yl]-2-methyl-5-morpholin-4-yl-4-oxopentanamide

C161H220N14O36 — CID 157483185

About (2R,5S)-N-[(2S)-3-(cyclohexen-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-2-[(4-methoxyphenyl)methyl]-5-[(2-morpholin-4-ylacetyl)amino]-5-(oxetan-3-yl)-4-oxopentanamide;(2R)-N-[(2S,5R)-5-(cyclopenten-1-ylmethyl)-1-(4-methoxyphenyl)-6-[(2R)-2-methyloxiran-2-yl]-3,6-dioxohexan-2-yl]-2-(3-morpholin-4-yl-2-oxopropyl)pent-4-ynamide;(2R)-N-[(2S,5R)-5-(cyclopenten-1-ylmethyl)-1-(2-methoxy-4-pyridinyl)-6-[(2R)-2-methyloxiran-2-yl]-3,6-dioxohexan-2-yl]-2-methyl-5-morpholin-4-yl-4-oxopentanamide;(2R)-N-[(2S,5R)-5-(cyclopenten-1-ylmethyl)-1-(6-methoxy-3-pyridinyl)-6-[(2R)-2-methyloxiran-2-yl]-3,6-dioxohexan-2-yl]-2-methyl-5-morpholin-4-yl-4-oxopentanamide;(2R)-N-[(2S,5R)-5-(cyclopenten-1-ylmethyl)-6-[(2R)-2-methyloxiran-2-yl]-1-(1-methyl-2-oxo-4-pyridinyl)-3,6-dioxohexan-2-yl]-2-methyl-5-morpholin-4-yl-4-oxopentanamide

(2R,5S)-N-[(2S)-3-(cyclohexen-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-2-[(4-methoxyphenyl)methyl]-5-[(2-morpholin-4-ylacetyl)amino]-5-(oxetan-3-yl)-4-oxopentanamide;(2R)-N-[(2S,5R)-5-(cyclopenten-1-ylmethyl)-1-(4-methoxyphenyl)-6-[(2R)-2-methyloxiran-2-yl]-3,6-dioxohexan-2-yl]-2-(3-morpholin-4-yl-2-oxopropyl)pent-4-ynamide;(2R)-N-[(2S,5R)-5-(cyclopenten-1-ylmethyl)-1-(2-methoxy-4-pyridinyl)-6-[(2R)-2-methyloxiran-2-yl]-3,6-dioxohexan-2-yl]-2-methyl-5-morpholin-4-yl-4-oxopentanamide;(2R)-N-[(2S,5R)-5-(cyclopenten-1-ylmethyl)-1-(6-methoxy-3-pyridinyl)-6-[(2R)-2-methyloxiran-2-yl]-3,6-dioxohexan-2-yl]-2-methyl-5-morpholin-4-yl-4-oxopentanamide;(2R)-N-[(2S,5R)-5-(cyclopenten-1-ylmethyl)-6-[(2R)-2-methyloxiran-2-yl]-1-(1-methyl-2-oxo-4-pyridinyl)-3,6-dioxohexan-2-yl]-2-methyl-5-morpholin-4-yl-4-oxopentanamide (PubChem CID 157483185) has the molecular formula C161H220N14O36 and a molecular weight of 2927.59 g/mol. Its IUPAC name is (2R,5S)-N-[(2S)-3-(cyclohexen-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-2-[(4-methoxyphenyl)methyl]-5-[(2-morpholin-4-ylacetyl)amino]-5-(oxetan-3-yl)-4-oxopentanamide;(2R)-N-[(2S,5R)-5-(cyclopenten-1-ylmethyl)-1-(4-methoxyphenyl)-6-[(2R)-2-methyloxiran-2-yl]-3,6-dioxohexan-2-yl]-2-(3-morpholin-4-yl-2-oxopropyl)pent-4-ynamide;(2R)-N-[(2S,5R)-5-(cyclopenten-1-ylmethyl)-1-(2-methoxy-4-pyridinyl)-6-[(2R)-2-methyloxiran-2-yl]-3,6-dioxohexan-2-yl]-2-methyl-5-morpholin-4-yl-4-oxopentanamide;(2R)-N-[(2S,5R)-5-(cyclopenten-1-ylmethyl)-1-(6-methoxy-3-pyridinyl)-6-[(2R)-2-methyloxiran-2-yl]-3,6-dioxohexan-2-yl]-2-methyl-5-morpholin-4-yl-4-oxopentanamide;(2R)-N-[(2S,5R)-5-(cyclopenten-1-ylmethyl)-6-[(2R)-2-methyloxiran-2-yl]-1-(1-methyl-2-oxo-4-pyridinyl)-3,6-dioxohexan-2-yl]-2-methyl-5-morpholin-4-yl-4-oxopentanamide.

Molecular Properties

• Compound Name: (2R,5S)-N-[(2S)-3-(cyclohexen-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-2-[(4-methoxyphenyl)methyl]-5-[(2-morpholin-4-ylacetyl)amino]-5-(oxetan-3-yl)-4-oxopentanamide;(2R)-N-[(2S,5R)-5-(cyclopenten-1-ylmethyl)-1-(4-methoxyphenyl)-6-[(2R)-2-methyloxiran-2-yl]-3,6-dioxohexan-2-yl]-2-(3-morpholin-4-yl-2-oxopropyl)pent-4-ynamide;(2R)-N-[(2S,5R)-5-(cyclopenten-1-ylmethyl)-1-(2-methoxy-4-pyridinyl)-6-[(2R)-2-methyloxiran-2-yl]-3,6-dioxohexan-2-yl]-2-methyl-5-morpholin-4-yl-4-oxopentanamide;(2R)-N-[(2S,5R)-5-(cyclopenten-1-ylmethyl)-1-(6-methoxy-3-pyridinyl)-6-[(2R)-2-methyloxiran-2-yl]-3,6-dioxohexan-2-yl]-2-methyl-5-morpholin-4-yl-4-oxopentanamide;(2R)-N-[(2S,5R)-5-(cyclopenten-1-ylmethyl)-6-[(2R)-2-methyloxiran-2-yl]-1-(1-methyl-2-oxo-4-pyridinyl)-3,6-dioxohexan-2-yl]-2-methyl-5-morpholin-4-yl-4-oxopentanamide
• PubChem CID: 157483185
• Molecular Formula: C161H220N14O36
• Molecular Weight: 2927.59 g/mol
• Exact Mass: 2925.58
• IUPAC Name: (2R,5S)-N-[(2S)-3-(cyclohexen-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-2-[(4-methoxyphenyl)methyl]-5-[(2-morpholin-4-ylacetyl)amino]-5-(oxetan-3-yl)-4-oxopentanamide;(2R)-N-[(2S,5R)-5-(cyclopenten-1-ylmethyl)-1-(4-methoxyphenyl)-6-[(2R)-2-methyloxiran-2-yl]-3,6-dioxohexan-2-yl]-2-(3-morpholin-4-yl-2-oxopropyl)pent-4-ynamide;(2R)-N-[(2S,5R)-5-(cyclopenten-1-ylmethyl)-1-(2-methoxy-4-pyridinyl)-6-[(2R)-2-methyloxiran-2-yl]-3,6-dioxohexan-2-yl]-2-methyl-5-morpholin-4-yl-4-oxopentanamide;(2R)-N-[(2S,5R)-5-(cyclopenten-1-ylmethyl)-1-(6-methoxy-3-pyridinyl)-6-[(2R)-2-methyloxiran-2-yl]-3,6-dioxohexan-2-yl]-2-methyl-5-morpholin-4-yl-4-oxopentanamide;(2R)-N-[(2S,5R)-5-(cyclopenten-1-ylmethyl)-6-[(2R)-2-methyloxiran-2-yl]-1-(1-methyl-2-oxo-4-pyridinyl)-3,6-dioxohexan-2-yl]-2-methyl-5-morpholin-4-yl-4-oxopentanamide
• SMILES: C#CC[C@H](CC(=O)CN1CCOCC1)C(=O)N[C@@H](Cc1ccc(OC)cc1)C(=O)C[C@@H](CC1=CCCC1)C(=O)[C@@]1(C)CO1.COc1cc(C[C@H](NC(=O)[C@H](C)CC(=O)CN2CCOCC2)C(=O)C[C@@H](CC2=CCCC2)C(=O)[C@@]2(C)CO2)ccn1.COc1ccc(C[C@H](CC(=O)[C@@H](NC(=O)CN2CCOCC2)C2COC2)C(=O)N[C@@H](CC2=CCCCC2)C(=O)[C@@]2(C)CO2)cc1.COc1ccc(C[C@H](NC(=O)[C@H](C)CC(=O)CN2CCOCC2)C(=O)C[C@@H](CC2=CCCC2)C(=O)[C@@]2(C)CO2)cn1.C[C@H](CC(=O)CN1CCOCC1)C(=O)N[C@@H](Cc1ccn(C)c(=O)c1)C(=O)C[C@@H](CC1=CCCC1)C(=O)[C@@]1(C)CO1
• InChI: InChI=1S/C34H47N3O8.C34H44N2O7.3C31H43N3O7/c1-34(22-45-34)32(40)28(17-23-6-4-3-5-7-23)35-33(41)25(16-24-8-10-27(42-2)11-9-24)18-29(38)31(26-20-44-21-26)36-30(39)19-37-12-14-43-15-13-37;1-4-7-26(20-28(37)22-36-14-16-42-17-15-36)33(40)35-30(19-25-10-12-29(41-3)13-11-25)31(38)21-27(18-24-8-5-6-9-24)32(39)34(2)23-43-34;1-21(14-25(35)19-34-10-12-40-13-11-34)30(38)33-26(16-23-8-9-28(39-3)32-18-23)27(36)17-24(15-22-6-4-5-7-22)29(37)31(2)20-41-31;1-21(14-25(35)19-34-10-12-40-13-11-34)30(39)32-26(16-23-8-9-33(3)28(37)17-23)27(36)18-24(15-22-6-4-5-7-22)29(38)31(2)20-41-31;1-21(14-25(35)19-34-10-12-40-13-11-34)30(38)33-26(16-23-8-9-32-28(17-23)39-3)27(36)18-24(15-22-6-4-5-7-22)29(37)31(2)20-41-31/h6,8-11,25-26,28,31H,3-5,7,12-22H2,1-2H3,(H,35,41)(H,36,39);1,8,10-13,26-27,30H,5-7,9,14-23H2,2-3H3,(H,35,40);6,8-9,18,21,24,26H,4-5,7,10-17,19-20H2,1-3H3,(H,33,38);6,8-9,17,21,24,26H,4-5,7,10-16,18-20H2,1-3H3,(H,32,39);6,8-9,17,21,24,26H,4-5,7,10-16,18-20H2,1-3H3,(H,33,38)/t25-,28+,31+,34-;26-,27-,30+,34-;3*21-,24-,26+,31-/m11111/s1
• InChIKey: BWJYRDIZLJNMOP-XFLHPNDNSA-N
• XLogP: 11.83
• TPSA: 632.51 Ų
• H-Bond Donors: 6
• H-Bond Acceptors: 44
• Rotatable Bonds: 80
• Heavy Atoms: 211
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	2927.59
LogP ≤ 5	11.83
H-Bond Donors ≤ 5	6
H-Bond Acceptors ≤ 10	44

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'dyes5A(27)', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}, {'alert_name': 'Three-membered_heterocycle', 'substructure': 'N/A'}, {'alert_name': 'triple_bond', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of (2R,5S)-N-[(2S)-3-(cyclohexen-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-2-[(4-methoxyphenyl)methyl]-5-[(2-morpholin-4-ylacetyl)amino]-5-(oxetan-3-yl)-4-oxopentanamide;(2R)-N-[(2S,5R)-5-(cyclopenten-1-ylmethyl)-1-(4-methoxyphenyl)-6-[(2R)-2-methyloxiran-2-yl]-3,6-dioxohexan-2-yl]-2-(3-morpholin-4-yl-2-oxopropyl)pent-4-ynamide;(2R)-N-[(2S,5R)-5-(cyclopenten-1-ylmethyl)-1-(2-methoxy-4-pyridinyl)-6-[(2R)-2-methyloxiran-2-yl]-3,6-dioxohexan-2-yl]-2-methyl-5-morpholin-4-yl-4-oxopentanamide;(2R)-N-[(2S,5R)-5-(cyclopenten-1-ylmethyl)-1-(6-methoxy-3-pyridinyl)-6-[(2R)-2-methyloxiran-2-yl]-3,6-dioxohexan-2-yl]-2-methyl-5-morpholin-4-yl-4-oxopentanamide;(2R)-N-[(2S,5R)-5-(cyclopenten-1-ylmethyl)-6-[(2R)-2-methyloxiran-2-yl]-1-(1-methyl-2-oxo-4-pyridinyl)-3,6-dioxohexan-2-yl]-2-methyl-5-morpholin-4-yl-4-oxopentanamide?

The IUPAC name of (2R,5S)-N-[(2S)-3-(cyclohexen-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-2-[(4-methoxyphenyl)methyl]-5-[(2-morpholin-4-ylacetyl)amino]-5-(oxetan-3-yl)-4-oxopentanamide;(2R)-N-[(2S,5R)-5-(cyclopenten-1-ylmethyl)-1-(4-methoxyphenyl)-6-[(2R)-2-methyloxiran-2-yl]-3,6-dioxohexan-2-yl]-2-(3-morpholin-4-yl-2-oxopropyl)pent-4-ynamide;(2R)-N-[(2S,5R)-5-(cyclopenten-1-ylmethyl)-1-(2-methoxy-4-pyridinyl)-6-[(2R)-2-methyloxiran-2-yl]-3,6-dioxohexan-2-yl]-2-methyl-5-morpholin-4-yl-4-oxopentanamide;(2R)-N-[(2S,5R)-5-(cyclopenten-1-ylmethyl)-1-(6-methoxy-3-pyridinyl)-6-[(2R)-2-methyloxiran-2-yl]-3,6-dioxohexan-2-yl]-2-methyl-5-morpholin-4-yl-4-oxopentanamide;(2R)-N-[(2S,5R)-5-(cyclopenten-1-ylmethyl)-6-[(2R)-2-methyloxiran-2-yl]-1-(1-methyl-2-oxo-4-pyridinyl)-3,6-dioxohexan-2-yl]-2-methyl-5-morpholin-4-yl-4-oxopentanamide (CID 157483185) is (2R,5S)-N-[(2S)-3-(cyclohexen-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-2-[(4-methoxyphenyl)methyl]-5-[(2-morpholin-4-ylacetyl)amino]-5-(oxetan-3-yl)-4-oxopentanamide;(2R)-N-[(2S,5R)-5-(cyclopenten-1-ylmethyl)-1-(4-methoxyphenyl)-6-[(2R)-2-methyloxiran-2-yl]-3,6-dioxohexan-2-yl]-2-(3-morpholin-4-yl-2-oxopropyl)pent-4-ynamide;(2R)-N-[(2S,5R)-5-(cyclopenten-1-ylmethyl)-1-(2-methoxy-4-pyridinyl)-6-[(2R)-2-methyloxiran-2-yl]-3,6-dioxohexan-2-yl]-2-methyl-5-morpholin-4-yl-4-oxopentanamide;(2R)-N-[(2S,5R)-5-(cyclopenten-1-ylmethyl)-1-(6-methoxy-3-pyridinyl)-6-[(2R)-2-methyloxiran-2-yl]-3,6-dioxohexan-2-yl]-2-methyl-5-morpholin-4-yl-4-oxopentanamide;(2R)-N-[(2S,5R)-5-(cyclopenten-1-ylmethyl)-6-[(2R)-2-methyloxiran-2-yl]-1-(1-methyl-2-oxo-4-pyridinyl)-3,6-dioxohexan-2-yl]-2-methyl-5-morpholin-4-yl-4-oxopentanamide.

What is the SMILES notation for (2R,5S)-N-[(2S)-3-(cyclohexen-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-2-[(4-methoxyphenyl)methyl]-5-[(2-morpholin-4-ylacetyl)amino]-5-(oxetan-3-yl)-4-oxopentanamide;(2R)-N-[(2S,5R)-5-(cyclopenten-1-ylmethyl)-1-(4-methoxyphenyl)-6-[(2R)-2-methyloxiran-2-yl]-3,6-dioxohexan-2-yl]-2-(3-morpholin-4-yl-2-oxopropyl)pent-4-ynamide;(2R)-N-[(2S,5R)-5-(cyclopenten-1-ylmethyl)-1-(2-methoxy-4-pyridinyl)-6-[(2R)-2-methyloxiran-2-yl]-3,6-dioxohexan-2-yl]-2-methyl-5-morpholin-4-yl-4-oxopentanamide;(2R)-N-[(2S,5R)-5-(cyclopenten-1-ylmethyl)-1-(6-methoxy-3-pyridinyl)-6-[(2R)-2-methyloxiran-2-yl]-3,6-dioxohexan-2-yl]-2-methyl-5-morpholin-4-yl-4-oxopentanamide;(2R)-N-[(2S,5R)-5-(cyclopenten-1-ylmethyl)-6-[(2R)-2-methyloxiran-2-yl]-1-(1-methyl-2-oxo-4-pyridinyl)-3,6-dioxohexan-2-yl]-2-methyl-5-morpholin-4-yl-4-oxopentanamide?

The canonical SMILES for (2R,5S)-N-[(2S)-3-(cyclohexen-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-2-[(4-methoxyphenyl)methyl]-5-[(2-morpholin-4-ylacetyl)amino]-5-(oxetan-3-yl)-4-oxopentanamide;(2R)-N-[(2S,5R)-5-(cyclopenten-1-ylmethyl)-1-(4-methoxyphenyl)-6-[(2R)-2-methyloxiran-2-yl]-3,6-dioxohexan-2-yl]-2-(3-morpholin-4-yl-2-oxopropyl)pent-4-ynamide;(2R)-N-[(2S,5R)-5-(cyclopenten-1-ylmethyl)-1-(2-methoxy-4-pyridinyl)-6-[(2R)-2-methyloxiran-2-yl]-3,6-dioxohexan-2-yl]-2-methyl-5-morpholin-4-yl-4-oxopentanamide;(2R)-N-[(2S,5R)-5-(cyclopenten-1-ylmethyl)-1-(6-methoxy-3-pyridinyl)-6-[(2R)-2-methyloxiran-2-yl]-3,6-dioxohexan-2-yl]-2-methyl-5-morpholin-4-yl-4-oxopentanamide;(2R)-N-[(2S,5R)-5-(cyclopenten-1-ylmethyl)-6-[(2R)-2-methyloxiran-2-yl]-1-(1-methyl-2-oxo-4-pyridinyl)-3,6-dioxohexan-2-yl]-2-methyl-5-morpholin-4-yl-4-oxopentanamide is C#CC[C@H](CC(=O)CN1CCOCC1)C(=O)N[C@@H](Cc1ccc(OC)cc1)C(=O)C[C@@H](CC1=CCCC1)C(=O)[C@@]1(C)CO1.COc1cc(C[C@H](NC(=O)[C@H](C)CC(=O)CN2CCOCC2)C(=O)C[C@@H](CC2=CCCC2)C(=O)[C@@]2(C)CO2)ccn1.COc1ccc(C[C@H](CC(=O)[C@@H](NC(=O)CN2CCOCC2)C2COC2)C(=O)N[C@@H](CC2=CCCCC2)C(=O)[C@@]2(C)CO2)cc1.COc1ccc(C[C@H](NC(=O)[C@H](C)CC(=O)CN2CCOCC2)C(=O)C[C@@H](CC2=CCCC2)C(=O)[C@@]2(C)CO2)cn1.C[C@H](CC(=O)CN1CCOCC1)C(=O)N[C@@H](Cc1ccn(C)c(=O)c1)C(=O)C[C@@H](CC1=CCCC1)C(=O)[C@@]1(C)CO1.

What is the InChIKey of (2R,5S)-N-[(2S)-3-(cyclohexen-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-2-[(4-methoxyphenyl)methyl]-5-[(2-morpholin-4-ylacetyl)amino]-5-(oxetan-3-yl)-4-oxopentanamide;(2R)-N-[(2S,5R)-5-(cyclopenten-1-ylmethyl)-1-(4-methoxyphenyl)-6-[(2R)-2-methyloxiran-2-yl]-3,6-dioxohexan-2-yl]-2-(3-morpholin-4-yl-2-oxopropyl)pent-4-ynamide;(2R)-N-[(2S,5R)-5-(cyclopenten-1-ylmethyl)-1-(2-methoxy-4-pyridinyl)-6-[(2R)-2-methyloxiran-2-yl]-3,6-dioxohexan-2-yl]-2-methyl-5-morpholin-4-yl-4-oxopentanamide;(2R)-N-[(2S,5R)-5-(cyclopenten-1-ylmethyl)-1-(6-methoxy-3-pyridinyl)-6-[(2R)-2-methyloxiran-2-yl]-3,6-dioxohexan-2-yl]-2-methyl-5-morpholin-4-yl-4-oxopentanamide;(2R)-N-[(2S,5R)-5-(cyclopenten-1-ylmethyl)-6-[(2R)-2-methyloxiran-2-yl]-1-(1-methyl-2-oxo-4-pyridinyl)-3,6-dioxohexan-2-yl]-2-methyl-5-morpholin-4-yl-4-oxopentanamide?

The InChIKey is BWJYRDIZLJNMOP-XFLHPNDNSA-N. The full InChI is InChI=1S/C34H47N3O8.C34H44N2O7.3C31H43N3O7/c1-34(22-45-34)32(40)28(17-23-6-4-3-5-7-23)35-33(41)25(16-24-8-10-27(42-2)11-9-24)18-29(38)31(26-20-44-21-26)36-30(39)19-37-12-14-43-15-13-37;1-4-7-26(20-28(37)22-36-14-16-42-17-15-36)33(40)35-30(19-25-10-12-29(41-3)13-11-25)31(38)21-27(18-24-8-5-6-9-24)32(39)34(2)23-43-34;1-21(14-25(35)19-34-10-12-40-13-11-34)30(38)33-26(16-23-8-9-28(39-3)32-18-23)27(36)17-24(15-22-6-4-5-7-22)29(37)31(2)20-41-31;1-21(14-25(35)19-34-10-12-40-13-11-34)30(39)32-26(16-23-8-9-33(3)28(37)17-23)27(36)18-24(15-22-6-4-5-7-22)29(38)31(2)20-41-31;1-21(14-25(35)19-34-10-12-40-13-11-34)30(38)33-26(16-23-8-9-32-28(17-23)39-3)27(36)18-24(15-22-6-4-5-7-22)29(37)31(2)20-41-31/h6,8-11,25-26,28,31H,3-5,7,12-22H2,1-2H3,(H,35,41)(H,36,39);1,8,10-13,26-27,30H,5-7,9,14-23H2,2-3H3,(H,35,40);6,8-9,18,21,24,26H,4-5,7,10-17,19-20H2,1-3H3,(H,33,38);6,8-9,17,21,24,26H,4-5,7,10-16,18-20H2,1-3H3,(H,32,39);6,8-9,17,21,24,26H,4-5,7,10-16,18-20H2,1-3H3,(H,33,38)/t25-,28+,31+,34-;26-,27-,30+,34-;3*21-,24-,26+,31-/m11111/s1.

What are the key properties of (2R,5S)-N-[(2S)-3-(cyclohexen-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-2-[(4-methoxyphenyl)methyl]-5-[(2-morpholin-4-ylacetyl)amino]-5-(oxetan-3-yl)-4-oxopentanamide;(2R)-N-[(2S,5R)-5-(cyclopenten-1-ylmethyl)-1-(4-methoxyphenyl)-6-[(2R)-2-methyloxiran-2-yl]-3,6-dioxohexan-2-yl]-2-(3-morpholin-4-yl-2-oxopropyl)pent-4-ynamide;(2R)-N-[(2S,5R)-5-(cyclopenten-1-ylmethyl)-1-(2-methoxy-4-pyridinyl)-6-[(2R)-2-methyloxiran-2-yl]-3,6-dioxohexan-2-yl]-2-methyl-5-morpholin-4-yl-4-oxopentanamide;(2R)-N-[(2S,5R)-5-(cyclopenten-1-ylmethyl)-1-(6-methoxy-3-pyridinyl)-6-[(2R)-2-methyloxiran-2-yl]-3,6-dioxohexan-2-yl]-2-methyl-5-morpholin-4-yl-4-oxopentanamide;(2R)-N-[(2S,5R)-5-(cyclopenten-1-ylmethyl)-6-[(2R)-2-methyloxiran-2-yl]-1-(1-methyl-2-oxo-4-pyridinyl)-3,6-dioxohexan-2-yl]-2-methyl-5-morpholin-4-yl-4-oxopentanamide?

(2R,5S)-N-[(2S)-3-(cyclohexen-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-2-[(4-methoxyphenyl)methyl]-5-[(2-morpholin-4-ylacetyl)amino]-5-(oxetan-3-yl)-4-oxopentanamide;(2R)-N-[(2S,5R)-5-(cyclopenten-1-ylmethyl)-1-(4-methoxyphenyl)-6-[(2R)-2-methyloxiran-2-yl]-3,6-dioxohexan-2-yl]-2-(3-morpholin-4-yl-2-oxopropyl)pent-4-ynamide;(2R)-N-[(2S,5R)-5-(cyclopenten-1-ylmethyl)-1-(2-methoxy-4-pyridinyl)-6-[(2R)-2-methyloxiran-2-yl]-3,6-dioxohexan-2-yl]-2-methyl-5-morpholin-4-yl-4-oxopentanamide;(2R)-N-[(2S,5R)-5-(cyclopenten-1-ylmethyl)-1-(6-methoxy-3-pyridinyl)-6-[(2R)-2-methyloxiran-2-yl]-3,6-dioxohexan-2-yl]-2-methyl-5-morpholin-4-yl-4-oxopentanamide;(2R)-N-[(2S,5R)-5-(cyclopenten-1-ylmethyl)-6-[(2R)-2-methyloxiran-2-yl]-1-(1-methyl-2-oxo-4-pyridinyl)-3,6-dioxohexan-2-yl]-2-methyl-5-morpholin-4-yl-4-oxopentanamide has a molecular weight of 2927.59 g/mol, XLogP of 11.83, 80 rotatable bonds, 6 hydrogen bond donors, and 44 hydrogen bond acceptors.

Where does this data come from?

All data for (2R,5S)-N-[(2S)-3-(cyclohexen-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-2-[(4-methoxyphenyl)methyl]-5-[(2-morpholin-4-ylacetyl)amino]-5-(oxetan-3-yl)-4-oxopentanamide;(2R)-N-[(2S,5R)-5-(cyclopenten-1-ylmethyl)-1-(4-methoxyphenyl)-6-[(2R)-2-methyloxiran-2-yl]-3,6-dioxohexan-2-yl]-2-(3-morpholin-4-yl-2-oxopropyl)pent-4-ynamide;(2R)-N-[(2S,5R)-5-(cyclopenten-1-ylmethyl)-1-(2-methoxy-4-pyridinyl)-6-[(2R)-2-methyloxiran-2-yl]-3,6-dioxohexan-2-yl]-2-methyl-5-morpholin-4-yl-4-oxopentanamide;(2R)-N-[(2S,5R)-5-(cyclopenten-1-ylmethyl)-1-(6-methoxy-3-pyridinyl)-6-[(2R)-2-methyloxiran-2-yl]-3,6-dioxohexan-2-yl]-2-methyl-5-morpholin-4-yl-4-oxopentanamide;(2R)-N-[(2S,5R)-5-(cyclopenten-1-ylmethyl)-6-[(2R)-2-methyloxiran-2-yl]-1-(1-methyl-2-oxo-4-pyridinyl)-3,6-dioxohexan-2-yl]-2-methyl-5-morpholin-4-yl-4-oxopentanamide is sourced from PubChem (CID 157483185), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).